---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-113646"
form_type: "8-K"
ticker: "FENC"
cik: "0001211583"
company_name: "FENNEC PHARMACEUTICALS INC."
filed_at: "2025-11-18T23:59:59+00:00"
generated_at: "2026-05-16T18:42:52.526455+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Fennec raises $5.025M in Canadian private placement, redeems $21.7M Petrichor notes

## Summary
- Issued 670,000 common shares at US$7.50 per share for gross proceeds of $5,025,000 from existing institutional shareholders in Canada (excl. Quebec).
- Offering closed November 18, 2025; shares registered under S-3 shelf and exempt from Canadian hold period.
- Net proceeds plus other funds to repurchase and redeem Petrichor convertible notes for ~$21.73 million, due Nov 19, 2025.
- Non-brokered, no placement agent; TSX approval obtained under Section 602.1 for interlisted issuer.

## SEC filing metadata
- accession: 0001104659-25-113646
- form_type: 8-K
- ticker: FENC
- cik: 0001211583
- company_name: FENNEC PHARMACEUTICALS INC.
- filed_at: 2025-11-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1211583/000110465925113646/0001104659-25-113646-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1211583/000110465925113646/tm2531509d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-113646
- JSON: https://secwatch.observer/filing/0001104659-25-113646.json
- Plain text: https://secwatch.observer/filing/0001104659-25-113646.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
